What is Qiming Venture Partners's contact information?

Qiming Venture Partners's contact information: BP@qimingvc.com, PR@qimingvc.com, contactus@qimingvc.com, +862161016522.

How many employees does Qiming Venture Partners have?

Qiming Venture Partners has 200 employees.

What industry does Qiming Venture Partners belong to?

Qiming Venture Partners is in the industry of: Venture Capital And Private Equity Principals, Internet.

What are Qiming Venture Partners's official social media profiles?

Qiming Venture Partners Linkedin Page Qiming Venture Partners Facebook Page Qiming Venture Partners Twitter Page

What tech stack does Qiming Venture Partners use?

Some of the popular technologies that Qiming Venture Partners uses are: Drupal, Microsoft 365, jQuery, Swiper.

What are Qiming Venture Partners's office addresses?

Qiming Venture Partners has a known office at the following address: Room 3901 Jinmao Tower, 88 Century Boulevard Hong Kong, HK.

What is Qiming Venture Partners's estimated annual revenue?

Qiming Venture Partners's revenue is $8,088,000

What is Qiming Venture Partners's open headcount?

Qiming Venture Partners has no job postings yet.

What is the number of ad campaigns for Qiming Venture Partners?

Qiming Venture Partners has no advertisements yet.

What is the number of recent news articles about Qiming Venture Partners?

Qiming Venture Partners has 45 news articles.

Qiming Venture Partners - Pubrio Company Profile & Intent

Qiming Venture Partners

Hong Kong · Venture Capital And Private Equity Principals

Venture Capital And Private Equity Principals

Internet

Qiming Venture Partners was founded in 2006. Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companies in the Technology and Healthcare industries at the early and growth stages. Since our debut, we have backed over 580 fast-growing and innovative companies. Over 210 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 80 portfolio companies that have achieved unicorn or super unicorn status. Many of our portfolio companies are today's most influential firms in their respective sectors, including Xiaomi (SEHK:1810), Meituan (SEHK:3690), Bilibili (NASDAQ:BILI, SEHK:9626), Zhihu (NYSE:ZH, SEHK:2390), Roborock (SHSE:688169), UBTech (SEHK:9880), WeRide (NASDAQ:WRD), HyperStrong (SHSE:688411), Insta360 (SHSE:688775), Unisound (SEHK:9678), Gan & Lee Pharmaceuticals (SHSE:603087), Tigermed (SZSE:300347, SEHK:3347), Zai Lab (NASDAQ:ZLAB, SEHK:9688), CanSino Biologics (SEHK:6185, SHSE:688185), Schrödinger (NASDAQ:SDGR), APT Medical (SHSE:688617), Sanyou Medical (SHSE:688085), AmoyDx (SZSE:300685), Berry Genomics (SZSE:000710), SinocellTech (SHSE:688520), Yuanxin Technology, Insilico Medicine, Medilink Therapeutics, LaNova Medicines, zai, StepFun, among many others.